Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study
Kaydedildi:
Paul, L.A., et al., Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study. Addiction, vol. 118, n. 4, 2023, p. 686-697.
Ref.
585291
Yer:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Opiáceos, Tratamiento médico, Recetas médicas, Fármacos, Terapia, Metadona, Buprenorfina, Efectos, Reducción de daños, Evaluación de servicios, EE.UU.
Drogodependencias, Opiáceos, Tratamiento médico, Recetas médicas, Fármacos, Terapia, Metadona, Buprenorfina, Efectos, Reducción de daños, Evaluación de servicios, EE.UU.
Benzer Materyaller: Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study
- The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study
- Interim opioid agonist treatment for opioid addiction: a systematic review
- Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA
- Comparing Canadian and United States opioid agonist therapy policies
- The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
- Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals